These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15007111)

  • 1. Intensive statin therapy--a sea change in cardiovascular prevention.
    Topol EJ
    N Engl J Med; 2004 Apr; 350(15):1562-4. PubMed ID: 15007111
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Gotto AM
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309745
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Miller M
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Statin therapy in patients with acute coronary syndrome. "Prove-it" study].
    von Schacky C
    Internist (Berl); 2004 Dec; 45(12):1437-9. PubMed ID: 15448925
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Paradis JM; LeLorier J
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309744
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Auer J; Weber T; Eber B
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15309747
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
    N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    van der Harst P; Voors AA; van Veldhuisen DJ
    N Engl J Med; 2004 Aug; 351(7):714-7; author reply 714-7. PubMed ID: 15306676
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
    Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
    Mega JL; Morrow DA; Cannon CP; Murphy S; Cairns R; Ridker PM; Braunwald E
    J Thromb Thrombolysis; 2006 Aug; 22(1):71-6. PubMed ID: 16786236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive lipid lowering with atorvastatin in coronary disease.
    Auer J; Lamm G; Eber B
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16000362
    [No Abstract]   [Full Text] [Related]  

  • 13. High-intensity statin treatment for coronary heart disease.
    Sacks FM
    JAMA; 2004 Mar; 291(9):1132-4. PubMed ID: 14996784
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein levels and outcomes after statin therapy.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):8-9. PubMed ID: 16455006
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive lipid lowering with atorvastatin in coronary disease.
    Southern W
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003831
    [No Abstract]   [Full Text] [Related]  

  • 19. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
    Wiviott SD; de Lemos JA; Cannon CP; Blazing M; Murphy SA; McCabe CH; Califf R; Braunwald E
    Circulation; 2006 Mar; 113(11):1406-14. PubMed ID: 16534008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.